Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Daniel Willis
French telecommunications specialist Invoxia is taking its expertise in the human GPS space into the companion animal market.
Amlan International has appointed Clare Mari Torralba to the role of regional sales director for the Asia Pacific region.
A new study by The Roslin Institute aims to identify genes that are vital in reducing infection of influenza A virus in pigs and chickens.
Research from Veramaris has revealed a strong connection between omega-3 eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) content in salmon, and increased salmon consumption frequency among US consumers.
Malmo-based Swedencare has opened a sales and marketing subsidiary based in Barcelona.
California-based Ark Animal Health began work on establishing a companion animal therapeutics portfolio in 2014. After five years, the company is readying the launch of its resiniferatoxin candidate. Animal Pharm analyst Daniel Willis spoke to Ark president Alexis Nahama at the recent Animal Health Investment Europe forum in London about the company's future plans.